Evaxion - Other Non-Current Liabilities 2020-2025 | EVAX

Evaxion - other non-current liabilities from 2020 to 2025. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
Evaxion - Annual Other Non-Current Liabilities
(Millions of US $)
2024 $0
2023 $0
2022 $0
2021 $0
2020 $0
2019 $0
Evaxion - Quarterly Other Non-Current Liabilities
(Millions of US $)
2024-06-30 $0
2023-06-30 $0
2022-06-30 $0
2022-03-31 $0
2021-12-31 $0
2021-09-30 $0
2021-06-30 $0
2021-03-31 $0
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.004B $0.003B
Evaxion A/S is a clinical-stage TechBio company specializing in developing AI-Immunology(TM) powered vaccines. Evaxion A/S, formerly known as Evaxion Biotech A/S, is based in COPENHAGEN, Denmark.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.427B 59.33
Hims & Hers Health (HIMS) United States $12.608B 131.00
Tempus AI (TEM) United States $10.745B 0.00
IRhythm Technologies (IRTC) United States $4.683B 0.00
Inspire Medical Systems (INSP) United States $4.012B 62.68
Hinge Health (HNGE) United States $3.034B 0.00
Privia Health (PRVA) United States $2.827B 193.25
Enovis (ENOV) United States $1.816B 10.12
Schrodinger (SDGR) United States $1.807B 0.00
Phreesia (PHR) United States $1.595B 0.00
Clover Health Investments (CLOV) United States $1.555B 0.00
Omnicell (OMCL) United States $1.452B 25.62
Azenta (AZTA) United States $1.316B 61.17
10x Genomics (TXG) United States $1.160B 0.00
Fulgent Genetics (FLGT) United States $0.652B 0.00
Claritev (CTEV) United States $0.650B 0.00
Butterfly Network (BFLY) United States $0.613B 0.00
Talkspace (TALK) United States $0.550B 164.50
Veradigm (MDRX) United States $0.476B 0.00
Standard BioTools (LAB) United States $0.403B 0.00
Outset Medical (OM) United States $0.371B 0.00
TruBridge (TBRG) United States $0.358B 794.00
Health Catalyst (HCAT) United States $0.285B 0.00
Nyxoah SA (NYXH) Belgium $0.261B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.209B 0.00
KORU Medical Systems (KRMD) United States $0.142B 0.00
EUDA Health Holdings (EUDA) Singapore $0.128B 0.00
Pulmonx (LUNG) United States $0.128B 0.00
American Well (AMWL) United States $0.109B 0.00
MDxHealth SA (MDXH) Belgium $0.098B 0.00
CareCloud (CCLD) United States $0.092B 3.52
111 (YI) China $0.073B 0.00
HeartBeam (BEAT) United States $0.056B 0.00
P3 Health Partners (PIII) United States $0.048B 0.00
Zepp Health (ZEPP) Netherlands $0.034B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.031B 0.00
Zhongchao (ZCMD) China $0.027B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Precipio (PRPO) United States $0.017B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00